GeoVax appoints Nicole Lemerond, CFA, to its Board of Directors

GeoVax Labs, Inc.

Nicole Lemerond appointed to GeoVax Board, effective August 31, 2022.
Ms. Lemerond brings over 25 years of healthcare finance experience including investment management, M&A, and private equity.
She has been appointed to the Audit Committee and will receive standard non-employee director compensation.
Her background includes roles at Lehman Brothers and The Carlyle Group.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicole Lemerond

Director

GOVX · GeoVax Labs, Inc.

Effective: 2022-08-31
Filed: September 1, 2022, 7:59 PM ET

On August 31, 2022, our Board of Directors (the “Board”) appointed Nicole Lemerond to the Board, effective as of August 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Lemerond was appointed as Director at GeoVax Labs, Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 31, 2022, our Board of Directors (the “Board”) appointed Nicole Lemerond to the Board, effective as of August 31, 2022.

View on SEC.gov

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-22-021688

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.